Latest News
Arbutus to Present at Jefferies London Healthcare Conference
GlobeNewswire - Thu Nov 14, 6:30AM CST
GlobeNewswire
Thu Nov 14, 6:30AM CST
Arbutus Reports Third Quarter 2024 Financial Results and Provides Corporate Update
GlobeNewswire - Wed Nov 6, 6:30AM CST
GlobeNewswire
Wed Nov 6, 6:30AM CST
Arbutus to Report Third Quarter 2024 Financial Results and Provide Corporate Update
GlobeNewswire - Wed Oct 23, 6:30AM CDT
GlobeNewswire
Wed Oct 23, 6:30AM CDT
Arbutus Announces Multiple Abstracts Highlighting Imdusiran Data Accepted for Presentation at AASLD - The Liver Meetingยฎ 2024
GlobeNewswire - Tue Oct 15, 7:16AM CDT
GlobeNewswire
Tue Oct 15, 7:16AM CDT
Arbutus to Present at H.C. Wainwright 5th Annual Viral Hepatitis Virtual Conference
GlobeNewswire - Tue Oct 1, 6:30AM CDT
GlobeNewswire
Tue Oct 1, 6:30AM CDT
Arbutus to Participate in Two Upcoming Investor Conferences
GlobeNewswire - Tue Sep 3, 6:30AM CDT
GlobeNewswire
Tue Sep 3, 6:30AM CDT
Arbutus Reports Second Quarter 2024 Financial Results and Provides Corporate Update
GlobeNewswire - Thu Aug 1, 6:30AM CDT
GlobeNewswire
Thu Aug 1, 6:30AM CDT
3 Outperforming Stocks to Buy With $500 Right Now
Barchart - Tue Jul 30, 8:04AM CDT
Barchart
Tue Jul 30, 8:04AM CDT
With a budget of around $500, investors can scoop up these three standout stock picks, which have outperformed the broader market in the past year.
Arbutus to Report Second Quarter 2024 Financial Results and Provide Corporate Update
GlobeNewswire - Thu Jul 18, 6:30AM CDT
GlobeNewswire
Thu Jul 18, 6:30AM CDT
Treatment with Arbutusโ Imdusiran and VTP-300 Achieves Statistical Significance in Lowering HBsAg Levels
GlobeNewswire - Thu Jun 6, 10:15AM CDT
GlobeNewswire
Thu Jun 6, 10:15AM CDT
Arbutusโ Imdusiran with Short Course Interferon Achieves Sustained Undetectable HBsAg, a Necessity for HBV Functional Cure
GlobeNewswire - Wed Jun 5, 1:30AM CDT
GlobeNewswire
Wed Jun 5, 1:30AM CDT
Arbutus to Participate in Jefferies Global Healthcare Conference
GlobeNewswire - Wed May 29, 6:30AM CDT
GlobeNewswire
Wed May 29, 6:30AM CDT
Arbutus to Present Imdusiran Data at EASL Congress 2024
GlobeNewswire - Wed May 22, 1:00AM CDT
GlobeNewswire
Wed May 22, 1:00AM CDT
Arbutus to Participate in Two Upcoming Investor Conferences
GlobeNewswire - Tue May 7, 6:30AM CDT
GlobeNewswire
Tue May 7, 6:30AM CDT
Arbutus Reports First Quarter 2024 Financial Results and Provides Corporate Update
GlobeNewswire - Thu May 2, 6:30AM CDT
GlobeNewswire
Thu May 2, 6:30AM CDT
Arbutus Announces Retirement of Chief Scientific Officer, Michael J. Sofia, PhD, Effective December 31, 2024
GlobeNewswire - Thu May 2, 6:25AM CDT
GlobeNewswire
Thu May 2, 6:25AM CDT
Arbutus to Report First Quarter 2024 Financial Results and Provide Corporate Update
GlobeNewswire - Thu Apr 18, 6:30AM CDT
GlobeNewswire
Thu Apr 18, 6:30AM CDT
Arbutus Biopharma Announces Claim Construction Ruling in its Ongoing Patent Infringement Lawsuit Against Moderna
GlobeNewswire - Thu Apr 4, 7:30AM CDT
GlobeNewswire
Thu Apr 4, 7:30AM CDT
Arbutus to Participate in Two Upcoming Investor Conferences
GlobeNewswire - Fri Mar 8, 6:30AM CST
GlobeNewswire
Fri Mar 8, 6:30AM CST
Arbutus Reports Fourth Quarter and Year End 2023 Financial Results and Provides Corporate Update
GlobeNewswire - Thu Feb 29, 6:30AM CST
GlobeNewswire
Thu Feb 29, 6:30AM CST
Arbutus to Report Fourth Quarter and Year End 2023 Financial Results and Provide Corporate Update
GlobeNewswire - Thu Feb 15, 6:30AM CST
GlobeNewswire
Thu Feb 15, 6:30AM CST
Arbutus Announces 2024 Corporate Objectives and Provides Financial Update
GlobeNewswire - Mon Jan 8, 6:30AM CST
GlobeNewswire
Mon Jan 8, 6:30AM CST
Arbutus Biopharma and Barinthus Bio Present Preliminary Data from Phase 2a Clinical Trial Combining Imdusiran with VTP-300 at AASLD - The Liver Meetingยฎ
GlobeNewswire - Thu Nov 9, 2023
GlobeNewswire
Thu Nov 9, 2023
Arbutus to Present at Jefferies London Healthcare Conference
GlobeNewswire - Wed Nov 8, 2023
GlobeNewswire
Wed Nov 8, 2023
Arbutus Reports Third Quarter 2023 Financial Results and Provides Corporate Update
GlobeNewswire - Tue Nov 7, 2023
GlobeNewswire
Tue Nov 7, 2023